Ind-Swift Laboratories Limited (INDSWFTLAB) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.015x

Based on the latest financial reports, Ind-Swift Laboratories Limited (INDSWFTLAB) has a cash flow conversion efficiency ratio of -0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-202.50 Million ≈ $-2.19 Million USD) by net assets (Rs13.07 Billion ≈ $141.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Ind-Swift Laboratories Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Ind-Swift Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Ind-Swift Laboratories Limited balance sheet liabilities for a breakdown of total debt and financial obligations.

Ind-Swift Laboratories Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ind-Swift Laboratories Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Arihant Superstructures Limited
NSE:ARIHANTSUP
-0.225x
Korea Computer & Systems Inc
KQ:115500
-0.094x
Gambling.com Group Ltd
NASDAQ:GAMB
-0.114x
Rawlplug S.A.
WAR:RWL
0.070x
Kutahya Seker Fabrikasi AS
IS:KTSKR
-0.005x
Cheops Technology France SA
PA:MLCHE
N/A
ParTec AG
XETRA:JY0
N/A
AB VILKUSKIU PIEN.EO 029
F:UDW
N/A

Annual Cash Flow Conversion Efficiency for Ind-Swift Laboratories Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Ind-Swift Laboratories Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Ind-Swift Laboratories Limited worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs11.73 Billion
≈ $126.85 Million
Rs-254.74 Million
≈ $-2.75 Million
-0.022x +89.19%
2024-03-31 Rs8.12 Billion
≈ $87.82 Million
Rs-1.63 Billion
≈ $-17.64 Million
-0.201x -170.38%
2023-03-31 Rs6.82 Billion
≈ $73.75 Million
Rs1.95 Billion
≈ $21.05 Million
0.285x +14.11%
2022-03-31 Rs6.01 Billion
≈ $64.98 Million
Rs1.50 Billion
≈ $16.25 Million
0.250x +11.83%
2021-03-31 Rs6.03 Billion
≈ $65.26 Million
Rs1.35 Billion
≈ $14.59 Million
0.224x +14.40%
2020-03-31 Rs6.41 Billion
≈ $69.28 Million
Rs1.25 Billion
≈ $13.54 Million
0.195x +278.44%
2019-03-31 Rs5.88 Billion
≈ $63.57 Million
Rs-644.00 Million
≈ $-6.96 Million
-0.110x -182.93%
2018-03-31 Rs5.53 Billion
≈ $59.83 Million
Rs730.90 Million
≈ $7.90 Million
0.132x -26.55%
2017-03-31 Rs5.31 Billion
≈ $57.46 Million
Rs955.66 Million
≈ $10.34 Million
0.180x +17.17%
2016-03-31 Rs5.17 Billion
≈ $55.96 Million
Rs794.30 Million
≈ $8.59 Million
0.154x -7.25%
2015-03-31 Rs5.95 Billion
≈ $64.30 Million
Rs983.98 Million
≈ $10.64 Million
0.166x +83.17%
2014-03-31 Rs7.25 Billion
≈ $78.43 Million
Rs655.29 Million
≈ $7.09 Million
0.090x +265.47%
2013-03-31 Rs8.53 Billion
≈ $92.30 Million
Rs-466.03 Million
≈ $-5.04 Million
-0.055x -161.11%
2012-03-31 Rs8.12 Billion
≈ $87.78 Million
Rs725.24 Million
≈ $7.84 Million
0.089x +193.19%
2011-03-31 Rs5.84 Billion
≈ $63.10 Million
Rs177.83 Million
≈ $1.92 Million
0.030x -69.08%
2010-03-31 Rs4.48 Billion
≈ $48.48 Million
Rs441.84 Million
≈ $4.78 Million
0.099x -64.25%
2009-03-31 Rs3.63 Billion
≈ $39.27 Million
Rs1.00 Billion
≈ $10.83 Million
0.276x +61.91%
2008-03-31 Rs3.33 Billion
≈ $36.06 Million
Rs567.77 Million
≈ $6.14 Million
0.170x +17.18%
2007-03-31 Rs3.11 Billion
≈ $33.68 Million
Rs452.62 Million
≈ $4.89 Million
0.145x +137.58%
2006-03-31 Rs1.92 Billion
≈ $20.80 Million
Rs117.63 Million
≈ $1.27 Million
0.061x --

About Ind-Swift Laboratories Limited

NSE:INDSWFTLAB India Drug Manufacturers - Specialty & Generic
Market Cap
$128.98 Million
Rs11.93 Billion INR
Market Cap Rank
#18218 Global
#956 in India
Share Price
Rs137.54
Change (1 day)
+1.07%
52-Week Range
Rs70.13 - Rs150.28
All Time High
Rs176.72
About

Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hy… Read more